Filings

6 documents · 80 matches

1. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-K 2026-03-31

   Item 1A. Risk Factors

   material weaknesses we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material
   13 matches in this document Show context Copy citation

2. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-05-15

   Item 1A. Risk Factors.

   material weaknesses we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material
   19 matches in this document Show context Copy citation

3. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2026-08-14

   Item 1A. Risk Factors.

   material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies
   12 matches in this document Show context Copy citation

4. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2026-05-15

   Item 1A. Risk Factors.

   material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies
   12 matches in this document Show context Copy citation

5. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-11-14

   Item 1A. Risk Factors.

   material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies
   12 matches in this document Show context Copy citation

6. BCLI BRAINSTORM CELL THERAPEUTICS INC. 10-Q 2025-08-14

   Item 1A. Risk Factors.

   material weakness in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies
   12 matches in this document Show context Copy citation